The 7th Due Diligence Summit for Life Sciences 2020 provide an overview of the proven strategies and insights of due diligence experts from biotechnology, medical device and pharmaceutical companies.
Topics
- Valuable insight from cross -functional due diligence team members, as well as leaders in the medical device and biotech industries
- BEST PRACTICES for companies of all sizes looking to acquire or in- license a product
- How to evaluate and effectively manage strategic alliances through case studies from industry leaders
- How to conduct a comprehensive intellectual property due diligence investigation, and how it can alter the strategy for your deal
- The regulatory and compliance standards of a target and how gaps can lead to unforeseen financial burdens
Who should Attend
Representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in:
- Business Development
- Due Diligence
- Mergers and Acquisitions
- Strategic Alliance/Alliance Management
- Intellectual Property and Patent Counsel
- Licensing
- Portfolio Management
- Search and Evaluation
- General Counsel/Corporate Counsel
- Scientific Assessment
- Regulatory Affairs
- Legal and Regulatory Compliance
- Clinical Medicine
- Research and Development
- Life Cycle Management
- Clinical Operations
